Takeda Announces New Assignments of Directors

Osaka, Japan, June 28, 2017 – Takeda Pharmaceutical Company Limited today announced new assignment of Directors. The details are as follows;

1. New assignment of Non-Audit and Supervisory Committee Directors effective June 28, 2017;

Name

Category

Role

Christophe Weber

Existing

Representative Director,

President & Chief Executive Officer

Masato Iwasaki

Existing

Director, President, Japan Pharma Business Unit

James Kehoe

New

Director, Chief Financial Officer

Andrew Plump

Existing

Director, Chief Medical & Scientific Officer

Masahiro Sakane

Existing

External Director

Yoshiaki Fujimori

Existing

External Director

Emiko Higashi

Existing

External Director

Michel Orsinger

Existing

External Director

Toshiyuki Shiga

Existing

External Director

Masahiro Sakane, an External Director, will chair the board meeting.

2. Audit and Supervisory Committee Directors ;

Name

Role

Yasuhiko Yamanaka

Director, Audit & Supervisory Committee member

Shiro Kuniya

External Director, Chairperson of Audit & Supervisory Committee

Koji Hatsukawa

External Director, Audit & Supervisory Committee member

Jean-Luc Butel

External Director, Audit & Supervisory Committee member

Audit and Supervisory Committee Directors are within their 2-year tenure, and were not subjects for reelection this year.


3. New assignment of Non-Audit and Supervisory Committee Directors effective June 28, 2017;

-     Compensation committee : Toshiyuki Shiga (Chair), Yoshiaki Fujimori, Yasuhiko Yamanaka

-     Nomination committee     : Masahiro Sakane (Chair), Emiko Higashi,

               Shiro Kuniya, Christophe Weber

 

 



Media Contact
Kazumi Kobayashi
Tel: +81-3-3278-2095
Email: kazumi.kobayashi@takeda.com

 

###